Role of primary chemoradiotherapy in the management of advanced stage vulvar cancer
Definitive (C)RT plays an important role in the management of advanced vulvar cancer with high response rates and satisfactory oncological outcomes. However, there is still room for improvement and future trials are needed to further assess the potential of definitive CRT, especially with regard to possible combinations with immunotherapy.
Authors
- L. Wessel
- Maria Vinsensia
- Nathalie Arians (ORCID: https://orcid.org/0000-0002-2389-5404)
- Jürgen Debus (ORCID: https://orcid.org/0000-0002-6411-4811)
- Thomas Koenigsmann
Institutions
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Heidelberger Institut für Radioonkologie (DE)
- National Center for Tumor Diseases (DE)
- Klinikum Ludwigshafen (DE)
- Deutsches Konsortium für Translationale Krebsforschung (DE)
Publication Details
- Journal
- Strahlentherapie und Onkologie
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1007/s00066-025-02483-z
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00